Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Pregnant women’s whooping cough vaccination rates on the rise

Pertussis, also known as whooping cough, is a bacterial infection that damages the lungs

A pregnant woman being vaccinated

Maternal vaccine uptake hits 73% in UK

Getty Images

Key Summary

  • Maternal whooping cough vaccination rates have risen to 73 per cent after a major outbreak affected over 3,000 people
  • The jab protects babies from a potentially fatal disease that caused 11 infant deaths in England last year
  • UKHSA urges all pregnant women to get vaccinated from 20 weeks to safeguard their newborns

The UK Health Security Agency (UKHSA) recently declared that the number of pregnant women coming forward for the whooping cough vaccine IS rising significantly.


Pertussis, also known as whooping cough, is a bacterial infection that damages the lungs with common symptoms like cold, runny nose or sore throat. Babies indicate this issue through a distinctive whoop, or through uneasy breathing.

The latest data shows maternal whooping cough vaccination rates have been rising steadily for seven months.

Unlike adults, whooping cough can lead to severe complications, even fatal for infants. The potential danger of the disease was reflected in the tragic death of 11 infants in England last year.

As per studies, timely vaccination can provide up to 91 per cent protection from infant death.

All babies get three doses of the 6-in-1 jab at 8, 12, and 16 weeks to protect against whooping cough, diphtheria, polio, and other serious diseases, followed by a pre-school booster at 3 years 4 months.

A whooping cough outbreak took place between 2023 and 2024 affecting over 3,000 people. With the constant urge of UKHSA, the vaccination rate that stood at 59 per cent last year has risen to 73 per cent in this March.

Staying at home and resting completely is crucial for whooping cough, to prevent the spread of the disease.

Anyone diagnosed with whooping cough must stay at home and rest until 48 hours after beginning antibiotics. People with symptoms, who do not use antibiotics must undergo rest for two weeks.

“While we’re making excellent progress, we want to ensure every expectant mother is offered the vaccine at the optimal time and understands that this vaccine is the best way to protect their baby during those crucial first weeks after birth. If you are pregnant and approaching 20 weeks, and haven’t been offered the whooping cough vaccine, please speak to your GP or midwife today to find out how you can get your vaccine,” said Dr Sharif Ismail, Consultant Epidemiologist at UKHSA.

“I strongly urge all pregnant women to get vaccinated when they become eligible and give the invaluable gift of protection to their newborn,” Ashley Dalton, Minister for Public Health and Prevention added.

More For You

Health services come under strain during winters

Community Pharmacy Northern Ireland has been involved in the Department of Health’s winter preparedness planning.

iStock

CPNI advocates whole-system approach to beat winter pressures

Key Summary

  • CPNI chief Gerard Greene met a group of MLAs to discuss measures to avert the health service crisis seen in previous winters
  • Community pharmacies will be involved in the Covid and winter flu vaccination service from the autumn
  • The vaccination drive will help avert flu outbreaks during winter and ease pressure on hospital services

Community Pharmacy Northern Ireland (CPNI) recently held a discussion with local political leaders about the need for a whole service, whole community approach to tackling this winter’s health pressures.

Keep ReadingShow less
GPhC, Pharmacist Support signed a memorandum of understanding (MoU)

The two organisations will collaborate to promote the well-being of pharmacists.

iStock

GPhC, Pharmacist Support join forces for well-being of pharmacy professionals

Key Summary

  • General Pharmaceutical Council and Pharmacist Support will advise each other on broad areas of concern
  • The two organisations will use joint resources to the benefit of both
  • They will work towards the well-being of pharmacy professionals, as it impacts their ability to keep patients safe

The General Pharmaceutical Council (GPhC) and Pharmacist Support have signed a memorandum of understanding (MoU) to support the well-being of pharmacy professionals.

Keep ReadingShow less
Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Professor Mahendra Patel hopes community pharmacies and GPs can “join hands to improve health outcomes” after he became the first pharmacist in England to be awarded an Honorary Fellowship by the Royal College of General Practitioners (RCGP).

Patel’s distinguished career in pharmacy has seen him make an incredible contribution to the sector in his roles in community pharmacy, health policy, professional leadership, and inclusive research nationally and internationally.

Keep ReadingShow less
 Health secretary Wes Streeting

Health secretary Wes Streeting says the focus will be on areas underserved by the NHS.

Pic credit: Getty images

NHS to focus on poorest areas to reduce healthcare inequalities

Key Summary

  • The government has announced a £2.2bn boost this year to improve healthcare in England’s poorest areas
  • GP funding and the GP contract to be reviewed to benefit working-class areas
  • A new pilot scheme to recruit an extra 1,000 NHS staff from areas worst affected by unemployment
  • New AI-powered features in the NHS app to reduce unequal access to information and choice

To reduce the stark inequalities in access to care and health outcomes, the government has announced a £2.2bn boost this year to improve healthcare in England’s poorest areas.

Keep ReadingShow less
AI Airlock programme - AI-powered healthcare innovation

Medicines and Healthcare products Regulatory Agency has received a £1 million boost for its AI Airlock programme.

iStock

MHRA's programme to support AI-powered healthcare innovation gets £1m boost

Key Summary

  • Under the AI Airlock programme, companies work directly with regulators to test new AI-powered medical devices
  • The programme is backed by the government’s new Regulatory Innovation Office
  • It cuts red tape and brings safe new technologies to patients in a shorter timeframe

Medicines and Healthcare products Regulatory Agency (MHRA) has received a £1 million boost for its AI Airlock programme, where companies can work directly with regulators to test new AI-powered medical devices.

Keep ReadingShow less